Parkure, a spin-out from Edinburgh developing a treatment for Parkinson’s disease, has raised £150,000 ($226,200) in a hybrid round of crowdfunding and government backing.
Half of the funding came via a round held on crowdfunding platform ShareIn, £25,000 short of its target. This was increased to £150,000 when the company receive a Smart Scotland grant from the Scottish Government at the turn of the year.
Parkure is using genetically engineered fruit flies with Parkinson’s to develop new drugs. The firm…
